Nexgel Valuation
| NXGL Stock | USD 1.30 0.01 0.76% |
Today, the firm appears to be undervalued. Nexgel Inc secures a last-minute Real Value of $2.45 per share. The latest price of the firm is $1.3. Our model forecasts the value of Nexgel Inc from analyzing the firm fundamentals such as Return On Equity of -0.53, profit margin of (0.25) %, and Current Valuation of 12.84 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Nexgel's valuation include:
Price Book 2.0413 | Enterprise Value | Enterprise Value Ebitda (0.85) | Price Sales 0.9074 | Forward PE 15.1976 |
Undervalued
Today
Please note that Nexgel's price fluctuation is dangerous at this time. Calculation of the real value of Nexgel Inc is based on 3 months time horizon. Increasing Nexgel's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nexgel stock is determined by what a typical buyer is willing to pay for full or partial control of Nexgel Inc. Since Nexgel is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nexgel Stock. However, Nexgel's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.3 | Real 2.45 | Target 6.0 | Hype 1.3 | Naive 1.43 |
The intrinsic value of Nexgel's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Nexgel's stock price.
Estimating the potential upside or downside of Nexgel Inc helps investors to forecast how Nexgel stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nexgel more accurately as focusing exclusively on Nexgel's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nexgel's intrinsic value based on its ongoing forecasts of Nexgel's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nexgel's closest peers.
Nexgel Cash |
|
Nexgel Total Value Analysis
Nexgel Inc is now forecasted to have valuation of 12.84 M with market capitalization of 15.55 M, debt of 2.83 M, and cash on hands of 9.79 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nexgel fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.84 M | 15.55 M | 2.83 M | 9.79 M |
Nexgel Investor Information
About 15.0% of the company outstanding shares are owned by corporate insiders. The book value of Nexgel was now reported as 0.64. The company recorded a loss per share of 0.4. Nexgel Inc had not issued any dividends in recent years. The entity had 3:2 split on the 2nd of August 1990. Nexgel Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Nexgel Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nexgel has an asset utilization ratio of 79.1 percent. This suggests that the Company is making $0.79 for each dollar of assets. An increasing asset utilization means that Nexgel Inc is more efficient with each dollar of assets it utilizes for everyday operations.Nexgel Profitability Analysis
Taking into consideration Nexgel's profitability measurements, Nexgel Inc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Nexgel's ability to earn profits and add value for shareholders.Net Loss | First Reported 2017-12-31 | Previous Quarter -665 K | Current Value -653 K | Quarterly Volatility 357.5 K |
For Nexgel profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nexgel Inc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nexgel utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nexgel's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nexgel over time as well as its relative position and ranking within its peers.
Nexgel Earnings per Share Projection vs Actual
By analyzing Nexgel's earnings estimates, investors can diagnose different trends across Nexgel's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Nexgel Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Nexgel Ownership Allocation
The market capitalization of Nexgel Inc is $15.55 Million. Nexgel Inc secures 15.39 % of its outstanding shares held by insiders and 6.43 % owned by institutional investors. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Nexgel Profitability Analysis
The company reported the previous year's revenue of 8.69 M. Net Loss for the year was (3.28 M) with profit before overhead, payroll, taxes, and interest of 4.64 M.About Nexgel Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Nexgel Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nexgel Inc based exclusively on its fundamental and basic technical indicators. By analyzing Nexgel's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Nexgel's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nexgel. We calculate exposure to Nexgel's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nexgel's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.2 M | 3.3 M | |
| Pretax Profit Margin | (0.46) | (0.48) | |
| Operating Profit Margin | (0.37) | (0.39) | |
| Net Loss | (0.43) | (0.46) | |
| Gross Profit Margin | 0.28 | 0.30 |
Nexgel Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nexgel does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 6.5 M | |
| Forward Price Earnings | 15.1976 |
Nexgel Current Valuation Indicators
Nexgel's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Nexgel's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Nexgel, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Nexgel's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Nexgel's worth.When determining whether Nexgel Inc is a strong investment it is important to analyze Nexgel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexgel's future performance. For an informed investment choice regarding Nexgel Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. Anticipated expansion of Nexgel directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexgel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.40) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Investors evaluate Nexgel Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nexgel's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Nexgel's market price to deviate significantly from intrinsic value.
It's important to distinguish between Nexgel's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexgel should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nexgel's market price signifies the transaction level at which participants voluntarily complete trades.